Rituximab combined with lenalidomide for the treatment of marginal zone lymphoma with IgM kappa positivity and cold agglutinin syndrome: a case report
Cold agglutinin disease (CAD) and cold agglutinin syndrome (CAS) are currently recognized as distinct clinical entities. CAD is defined as a distinct clonal B-cell lymphoproliferative disorder of the bone marrow. CAD is also a subgroup of autoimmune hemolytic anemia, triggered by cold-reactive immun...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2026-04-01
|
| Saila: | Frontiers in Immunology |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1780180/full |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|